IPO Plus

8,388

+10.05 +0.12%

05 Aug 2026

NSE Listed · Pharmaceuticals

Divis Laboratories Ltd. (DIVISLAB)

Volume: 3,16,801Avg Vol 1W: 9,06,129Avg Vol 1M: 5,82,18752W Range:5,636.58,585
Market Cap₹2,22,675 Cr
Current Price₹8,388
Previous Close₹8,377.95
High / Low (52w)₹8,585 / ₹5,636.5
Volume3,16,801
Avg Vol (1W)9,06,129
Avg Vol (1M)5,82,187
Stock P/E296.29
Book Value₹632.49
Dividend Yield0.45%
ROE15.32%
ROA12.82%
Revenue (TTM)
Revenue Growth19.31%
Profit Margin24.32%
Total Debt₹0 Cr
Shares Outstanding27 Cr
Face Value₹2
EPS (TTM)₹28.31
P/B13.26
Debt / Equity0
50 DMA₹7,008.36
200 DMA₹6,533.86
Day change+0.12%
Price Chart
8,388 30.88% · 1Y
8585569019.3L
2025-08-05
2026-08-05

20-day avg volume: 6.0L shares

Pros
  • Healthy return on equity of 15.3%.
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 296.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹2,338 Cr₹2,319 Cr₹2,585 Cr₹2,410 Cr₹2,715 Cr₹2,604 Cr₹2,831 Cr₹3,080 Cr
EBITDA₹723 Cr₹726 Cr₹865 Cr₹736 Cr₹920 Cr₹860 Cr₹969 Cr₹1,186 Cr
Net Profit₹510 Cr₹589 Cr₹662 Cr₹545 Cr₹689 Cr₹583 Cr₹751 Cr₹902 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹9,712 Cr₹2,536 Cr₹2,357 Cr₹2,660 Cr₹2,578 Cr₹2,793 Cr₹11,067 Cr₹2,974 Cr
EBITDA₹2,918 Cr₹861 Cr₹750 Cr₹928 Cr₹878 Cr₹977 Cr₹3,485 Cr₹1,171 Cr
Net Profit₹2,191 Cr₹667 Cr₹557 Cr₹696 Cr₹598 Cr₹756 Cr₹2,568 Cr₹891 Cr
EPS82.5396.75
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹8,038 Cr₹8,536 Cr₹10,774 Cr₹13,375 Cr₹14,439 Cr₹15,470 Cr₹16,932 Cr₹20,033 Cr
Total Liabilities₹1,081 Cr₹1,226 Cr₹1,479 Cr₹1,647 Cr₹1,672 Cr₹1,899 Cr₹1,963 Cr₹3,272 Cr
Equity₹6,957 Cr₹7,310 Cr₹9,295 Cr₹11,728 Cr₹12,767 Cr₹13,571 Cr₹14,969 Cr₹16,761 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1,439 Cr₹1,661 Cr₹2,591 Cr₹2,553 Cr₹2,932 Cr₹1,637 Cr₹2,477 Cr₹3,600 Cr
Investing₹-685 Cr₹-83 Cr₹75 Cr₹-2,195 Cr₹-2,708 Cr₹-269 Cr₹-804 Cr₹-2,219 Cr
Financing₹-246 Cr₹-1,091 Cr₹-35 Cr₹-532 Cr₹-797 Cr₹-799 Cr₹-799 Cr₹-804 Cr
Free Cash Flow₹1,439 Cr₹1,661 Cr₹2,591 Cr₹2,553 Cr₹2,932 Cr₹1,637 Cr₹2,477 Cr₹3,600 Cr
Shareholding
Promoter 51.88% Institutions 39.58% Public 8.54%
Efficiency & Working Capital
ROCE20.6%
Interest Coverage142.2
Dividend Payout
Debtor Days103 d
Inventory Days137 d
Payable Days42 d
Cash Conversion Cycle198 d
Working Capital Days240 d
Shareholding Details

As of 2026-06-30

Promoter51.9%
FII20.2%
DII19.4%
Institutions39.6%
Public8.5%
Promoter Pledge0%
No. of Shareholders2,26,324
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters51.9%51.9%51.9%51.9%51.9%51.9%51.9%51.9%51.9%51.9%51.9%51.9%
FIIs14.6%14.9%14.7%16.2%17.3%18%18%19.7%19.4%20.1%20.3%20.2%
DIIs21%21.9%22.2%21.8%21.1%20.5%20.7%19.1%19.8%19.3%19.2%19.4%
Public12.5%11.3%11.2%10.2%9.8%9.6%9.4%9.3%9%8.8%8.6%8.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3,73,8603,54,4823,47,6292,98,3102,78,8992,80,6012,67,7552,59,8252,49,6342,33,8442,28,0062,26,324
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Satchandra Kiran DiviShareholding of Promoter and Promoter Group20.3%5.40 Cr
Nilima Prasad DiviShareholding of Promoter and Promoter Group20.3%5.40 Cr
Swarna Latha DiviShareholding of Promoter and Promoter Group5.3%1.40 Cr
Sbi Mutual FundPublic Shareholding3.9%1.04 Cr
Government Of SingaporePublic Shareholding3.6%96,51,126
Divi's Biotech Private LimitedShareholding of Promoter and Promoter Group3%80,00,000
Murali Krishna Prasad DiviShareholding of Promoter and Promoter Group2.9%75,67,000
Life Insurance Corporation Of IndiaPublic Shareholding2.5%67,10,553
Hdfc Mutual FundPublic Shareholding2.1%54,95,065
Axis Mutual Fund Trustee LimitedPublic Shareholding1.4%36,75,501
Nippon Life India Trustee LtdPublic Shareholding1.3%34,34,650
Government Pension Fund GlobalPublic Shareholding1.2%32,63,040
Madhusudana Rao DiviShareholding of Promoter and Promoter Group0.1%1,68,090
Radhakrishna Rao DiviShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Ramesh B V NimmagaddaChairman & Independent Directo2026
Murali K DiviExecutive Director & MD2026
N V RamanaExecutive Director2026
Kiran S DiviExecutive Director / Whole Time Director / CEO2026
Nilima Prasad DiviED / WTD - Commercial2026
S. Devendra RaoExecutive Director / Whole Time Director2026
S GanapatyIndependent Non Exe. Director2026
Sunaina SinghIndependent Non Exe. Director2026
Kosaraju Veerayya ChowdaryIndependent Non Exe. Director2026
Rajendrakumar Premchand ShahIndependent Non Exe. Director2026
Satish ChoudhuryCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Manufacture of Active Pharmaceutica₹0 Cr
Segments — Geography
RegionRevenueShare
Europe₹6,311 Cr60.8%
America₹1,360 Cr13.1%
Asia₹1,079 Cr10.4%
India₹1,159 Cr11.2%
Rest of the world₹479 Cr4.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2605353
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-01Board Meetings
forthcoming2026-07-24Dividend (30/- per share)Final
dividend2026-07-24₹30 (1500%)Final
dividend2025-07-25₹30 (1500%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026966007921231,928
202600001818
202645600792551,350
Insider / Designated-Person Trades

15 recent disclosure(s)

Donepudi Venkata SohiniAcquisition · 351
Nimmagadda Venkata AnirudhDisposal · 4,200
G.V.PraneethAcquisition · 300
G. KelithaDisposal · 300
Nimmagadda Venkata AnirudhDisposal · 15,800
D RadhikaAcquisition · 400
Substantial Acquisitions (SAST)

1 disclosure(s)

Market19/02/2025 · 1,40,560
Company Information
Incorporated1990
ChairmanRamesh B V Nimmagadda
AuditorPrice Waterhouse Chartered Accountants LLP
🌐 www.divislabs.com

📍 1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli, Hyderabad, Telangana, 500032

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App